financetom
Business
financetom
/
Business
/
BHP considering improved proposal for Anglo American after bid was rejected, source says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BHP considering improved proposal for Anglo American after bid was rejected, source says
Apr 27, 2024 9:03 AM

(Reuters) -BHP Group is considering making an improved proposal for Anglo American after its $39 billion initial offer was rejected by the London-listed miner, a source familiar with the matter told Reuters.

BHP is in discussion for revised proposal for Anglo American in the coming weeks, the source said. The deliberations are currently ongoing and it has not made a decision on the size and structure of the new proposal, the source added.

BHP and Anglo American did not immediately respond to a Reuters request for comment.

Anglo American had rejected BHP's $39 billion takeover offer on Friday saying it significantly undervalued the miner and its future prospects.

BHP has until May 22 to come back with a formal offer for Anglo American. It is expected to sweeten its 25.08 pound per share offer to try to clinch a deal that would create the world's biggest miner of copper, a metal central to the clean energy shift.

Much of the focus of BHP's bid has been on copper. A tie-up with Anglo would forge a group accounting for about 10% of global output of the metal, which due to its conductivity and resistance to corrosion is used in everything from electric vehicles and power grids to construction.

A deal, if successful, would be the largest mining takeover globally in 2024 and among the top 10 largest deals for the sector ever, LSEG data showed.

Bloomberg News first reported the news about BHP's improved proposal for Anglo American.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Majestic Ideal Holdings Ltd IPOs Tomorrow, Here's What You Need To Know
Majestic Ideal Holdings Ltd IPOs Tomorrow, Here's What You Need To Know
Jul 1, 2024
MAJESTIC IDEAL HOLDINGS LTD IPO will take place July, 02 on the NASDAQ exchange under the ticker MJID. The company is offering shares at an expected price between $4.00 and $5.00 per share with an insider lock-up period of 180 days ending on December 29, 2024. See also: Benzinga IPO Calendar About MAJESTIC IDEAL HOLDINGS LTD MAJESTIC IDEAL HOLDINGS LTD...
Supreme Court Overturns Debit Card Swipe-Fee Ruling of Lower Court
Supreme Court Overturns Debit Card Swipe-Fee Ruling of Lower Court
Jul 1, 2024
10:29 AM EDT, 07/01/2024 (MT Newswires) -- The US Supreme Court on Monday ruled that a North Dakota convenience store and truck stop can sue over a 2011 rule dictating the charges that financial institutions can impose on merchants, overturning a ruling by a US District Court that was affirmed by the US Court of Appeals for the Eighth Circuit....
What's Going On With Shares Of Bitcoin Miner Bitfarms Today?
What's Going On With Shares Of Bitcoin Miner Bitfarms Today?
Jul 1, 2024
Bitfarms Ltd ( BITF ) shares are trading higher. The company on Monday provided a production and operations update for June. What Happened: Bitfarms ( BITF ) said it mined 189 Bitcoin (CRYPTO: BTC) last month compared to 156 bitcoin in May as a result of increasing corporate hashrate during the month. The company noted that curtailment in Argentina and downtime...
Senti Biosciences (SNTI) Stock Is Up Over 100%: What's Happening?
Senti Biosciences (SNTI) Stock Is Up Over 100%: What's Happening?
Jul 1, 2024
Senti Biosciences Inc ( SNTI ) shares are trading higher by 102.6% to $0.56 during Monday’s session after the company was awarded $8 million from the California Institute for Regenerative Medicines, which will support the ongoing development of SENTI-202. The company says SENTI-202 is an investigational cell therapy for treating relapsed/refractory hematologic malignancies, including acute myeloid leukemia (AML). The ongoing Phase 1...
Copyright 2023-2026 - www.financetom.com All Rights Reserved